Related Experiment Video

Updated: Jan 17, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.8K

Lichen planus onset during interleukin 23 blockade for treatment of psoriasis

Alia Abbas1, Andrew Schroeder2, Carly Elston1

  • 1Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama.

JAAD Case Reports
|September 15, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
cytokinesdrug reactionsinterleukinslichen planuspsoriasis

More Related Videos

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

15.1K

Related Experiment Videos

Last Updated: Jan 17, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.8K
Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

15.1K

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.8K

Articles linked to this work by shared authors, journal, and citation graph.

Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management.

Journal of the National Cancer Institute·2026

CD151 identifies a cytotoxic CD4 T cell population enriched in people with HIV that later develop cancer.

Journal of immunology (Baltimore, Md. : 1950)·2026

Trichophyton indotineae: Rise, Diagnosis, Treatment, and Future Directions.

American journal of clinical dermatology·2026

Proximity of Wildfires to Inpatient Healthcare Facilities in California, 2001-2023.

GeoHealth·2026

Bimekizumab efficacy in scalp, nail and palmoplantar psoriasis versus comparators and over 4 years.

The Journal of dermatological treatment·2026

Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants.

Journal of drugs in dermatology : JDD·2026

Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature.

Acta oncologica (Stockholm, Sweden)·2026

Connecting Skin and Gut in Dermatitis Herpetiformis: Insights from Gluten Challenge Transcriptomics.

Acta dermato-venereologica·2026

Correlation Analysis Between Increased CD63 Expression Detected by Eosinophil Activation Test and sIgE Levels.

Scandinavian journal of immunology·2026

Severe Dupilumab-Associated Psoriasis Flare After Switching From Ustekinumab for Biopsy-Proven Eczematous Dermatitis: A Case Report.

Cureus·2026

Diagnostic utility of endotracheal aspirate galactomannan for invasive pulmonary aspergillosis in ICU patients.

Le infezioni in medicina·2026

Low-dose allergen targeting to cDC2 induces long-term protection associated with induction of regulatory-like IL-10+ Foxp3- CD8+ T cells in mice.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us